109 related articles for article (PubMed ID: 4077112)
21. Alopecia areata in children: treatment with diphencyprone.
Schuttelaar ML; Hamstra JJ; Plinck EP; Peereboom-Wynia JD; Vuzevski VD; Mulder PG; Oranje AP
Br J Dermatol; 1996 Oct; 135(4):581-5. PubMed ID: 8915150
[TBL] [Abstract][Full Text] [Related]
22. Immunotherapy for resistant and/or severe alopecia areata in a university hospital setting in Northern Mexico.
Herz-Ruelas ME; Lozano-Peña AK; Ocampo-Candiani J; Gómez-Flores M; Welsh-Lozano O; Vázquez-Martínez O
Australas J Dermatol; 2020 Feb; 61(1):e137-e139. PubMed ID: 31385296
[No Abstract] [Full Text] [Related]
23. Predictive model for immunotherapy of alopecia areata with diphencyprone.
Wiseman MC; Shapiro J; MacDonald N; Lui H
Arch Dermatol; 2001 Aug; 137(8):1063-8. PubMed ID: 11493099
[TBL] [Abstract][Full Text] [Related]
24. [Alopecia areata; pathogenesis and topical immunotherapy].
Perret CM; Steijlen PM; Happle R
Ned Tijdschr Geneeskd; 1989 Jun; 133(25):1256-60. PubMed ID: 2666865
[No Abstract] [Full Text] [Related]
25. The safety and efficacy of diphencyprone for the treatment of alopecia areata in children.
Salsberg JM; Donovan J
Arch Dermatol; 2012 Sep; 148(9):1084-5. PubMed ID: 22986874
[No Abstract] [Full Text] [Related]
26. Induction of hair growth in alopecia totalis with diphencyprone sensitization.
Monk B
Clin Exp Dermatol; 1989 Mar; 14(2):154-7. PubMed ID: 2598490
[TBL] [Abstract][Full Text] [Related]
27. Prolonged dermatitis distant to the site of squaric acid dibutyl ester applications and recovery of alopecia areata.
Ujiie H; Sawamura D; Shibaki A; Shimizu H
Clin Exp Dermatol; 2005 Sep; 30(5):579-80. PubMed ID: 16045698
[No Abstract] [Full Text] [Related]
28. [Treatment of alopecia areata with diphencyprone].
Suditu G; Toma A; Voiculescu M
Rev Med Chir Soc Med Nat Iasi; 2001; 105(4):760-2. PubMed ID: 12092234
[TBL] [Abstract][Full Text] [Related]
29. Squaric acid dibutylester treatment of alopecia areata.
Valsecchi R; Cainelli T; Tornaghi A; Rossi A; Perego GB; Smojver E; Panunzio M
Clin Exp Dermatol; 1985 May; 10(3):233-8. PubMed ID: 4006285
[No Abstract] [Full Text] [Related]
30. Treatment of alopecia totalis with a combination of inosine pranobex and diphencyprone compared to each treatment alone.
Berth-Jones J; Hutchinson PE
Clin Exp Dermatol; 1991 May; 16(3):172-5. PubMed ID: 1718636
[TBL] [Abstract][Full Text] [Related]
31. Topical immunotherapy of alopecia areata. A follow-up study.
Valsecchi R; Cainelli T; Foiadelli L; Rossi A
Acta Derm Venereol; 1986; 66(3):269-72. PubMed ID: 2426909
[TBL] [Abstract][Full Text] [Related]
32. Role of topical immunotherapy in the treatment of alopecia areata. Quality analysis of articles published between January 1977 and January 1988 about three treatments. Reading Group.
Naldi L; Parazzini F; Cainelli T
J Am Acad Dermatol; 1990 Apr; 22(4):654-6. PubMed ID: 2138637
[TBL] [Abstract][Full Text] [Related]
33. Topical immunomodulator therapy with squaric acid dibutylester (SADBE) is effective treatment for severe alopecia areata (AA): results of an open-label, paired-comparison, clinical trial.
Dall'oglio F; Nasca MR; Musumeci ML; La Torre G; Ricciardi G; Potenza C; Micali G
J Dermatolog Treat; 2005 Feb; 16(1):10-4. PubMed ID: 15897160
[TBL] [Abstract][Full Text] [Related]
34. Normalisation of hair follicle morphology in C3H/HeJ alopecia areata mice after treatment with squaric acid dibutylester.
Gardner S; Freyschmidt-Paul P; Hoffmann R; Sundberg JP; Happle R; Lindsey NJ; Tobin DJ
Eur J Dermatol; 2000 Aug; 10(6):443-50. PubMed ID: 10980465
[TBL] [Abstract][Full Text] [Related]
35. Topical diphencyprone for alopecia areata: evaluation of 48 cases after 30 months' follow-up.
Gordon PM; Aldrige RD; McVittie E; Hunter JA
Br J Dermatol; 1996 May; 134(5):869-71. PubMed ID: 8736327
[TBL] [Abstract][Full Text] [Related]
36. Diphenylcyclopropenone (diphencyprone, DPCP) in the treatment of chronic severe alopecia areata (AA).
Galadari I; Rubaie S; Alkaabi J; Galadari H
Eur Ann Allergy Clin Immunol; 2003 Dec; 35(10):397-401. PubMed ID: 14768526
[TBL] [Abstract][Full Text] [Related]
37. Topical immunotherapy with contact allergens in alopecia areata: evidence for non-specific systemic suppression of cellular immune reactions.
Bröcker EB; John SM; Steinhausen D; Hamm H
Arch Dermatol Res; 1991; 283(2):133-4. PubMed ID: 2069412
[No Abstract] [Full Text] [Related]
38. Squaric acid dibutylester: indications for use and efficacy in alopecia areata.
Pardasani AG; Turner E; McMichael AJ
Arch Dermatol; 2001 Jul; 137(7):970-2. PubMed ID: 11453831
[No Abstract] [Full Text] [Related]
39. Treatment of alopecia areata with squaric acid dibutylester.
Caserio RJ
Arch Dermatol; 1987 Aug; 123(8):1036-41. PubMed ID: 3307636
[TBL] [Abstract][Full Text] [Related]
40. Treatment of alopecia areata with squaric acid dibutylester.
Hill ND; Bunata K; Hebert AA
Clin Dermatol; 2015; 33(3):300-4. PubMed ID: 25889130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
